Actinium Pharmaceuticals – Page 2

March 28, 2018 Off

Actinium to work with Astellas Pharma on its AWE Platform Technology

Actinium Pharmaceuticals and Astellas Pharma will work together to develop Actinium-225 Radio-Conjugates (ARCs) using Actinium Warhead Enabling (AWE) Platform Technology,…

March 13, 2018 Off

ARC’s in combination with chemotherapy could be exciting development opportunity for AMLeukemia patients, MC of Wisconsin cleared to study Actimab-A+CLAG-M

By Dino Mustafić

A Phase 1 trial of Actimab-A in combination with CLAG-M for relapsed or refractory Acute Myeloid Leukemia (AML) patients, will be…

February 12, 2018 Off

Actinium seeks chance to maximize value for partners and collaborators, applies Acute Myeloid Leukemia treatment for investigation

By Dino Mustafić

Actinium Pharmaceuticals has applied an Investigational New Drug for Actimab-A combined with CLAG-M, for Acute Myeloid Leukemia, to the USFDA.